Tumor-binding antibodies induce potent dendritic cell-mediated tumor immunity

Yaron Carmi, Tyler Prestwood, Edgar G. Engleman

Research output: Contribution to journalArticlepeer-review


The factors that determine the impact of antitumor antibodies on tumor progression are poorly defined. We found that the tumor microenvironment holds the key. In the absence of dendritic cell (DC) stimulation, such antibodies provide little benefit, but in a stimulatory context they can initiate potent antitumor immunity.

Original languageEnglish
Article numbere1078063
Issue number10
StatePublished - 1 Jan 2019
Externally publishedYes


  • Dendritic cells
  • Fc receptors
  • Tumor-binding antibodies

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology


Dive into the research topics of 'Tumor-binding antibodies induce potent dendritic cell-mediated tumor immunity'. Together they form a unique fingerprint.

Cite this